Global Retirement Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
RI
SPPAM
Global Retirement Partners's CSTL Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Castle Biosciences (CSTL) in Q2 2026: 1,100 shares worth $26.2K. The stake represents ﹤0.01% of the portfolio and ranks #2902 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CSTL as recently as Q4 2025.
Global Retirement Partners first reported a position in CSTL in Q4 2019 and has held it in 25 quarters since. The position peaked at $42.8K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.
- Global Retirement Partners held 1,100 shares of Castle Biosciences worth $26.2K as of Q2 2026.
- Castle Biosciences was a new Global Retirement Partners position in Q2 2026.
- Castle Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2902 holding.
- Global Retirement Partners first reported a position in Castle Biosciences in Q4 2019 and has held it in 25 quarters since.
- Global Retirement Partners's Castle Biosciences position peaked at $42.8K in Q4 2025.
- 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.